Venous Thromboembolism Treatment Outlook - 2022-2029
[243 Pages Report] The global Venous Thromboembolism Treatment Market is expected to exceed US$ 1.53 Billion by 2022. Growing acceptance of novel venous thromboembolism treatment devices in emerging economies such as India, China, Brazil, and Russia among others is estimated to facilitate the growth in the market.
Attribute
Details
Venous Thromboembolism Treatment Market Estimated Size in 2022
US$ 1.53 Billion
Venous Thromboembolism Treatment Market Projected Size in 2029
US$ 1.91 Billion
Venous Thromboembolism Treatment Market Historical CAGR (2014 to 2021)
3.7%
Venous Thromboembolism Treatment Market Value-based CAGR (2022 to 2029)
3.7%
Future Market Insights (FMI) states that the demand in the global venous thromboembolism treatment market is projected to surge at 3.7% CAGR during the forecast period 2022 to 2029.
The deep venous thrombosis segment is anticipated to account for more than 3/5th of venous thromboembolism treatment sales by 2022, reveals FMI. Also, percutaneous thrombectomy devices and catheter-directed thrombolysis devices are estimated to collectively account for over half of the demand share through 2029.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
How The Market Progressed Till June 2022?
Particulars
Details
H1, 2021
3.97%
H1, 2022 Projected
3.65%
H1, 2022 Outlook
3.15%
BPS Change - H1, 2022 (O) - H1, 2022 (P)
(-) 50 ↓
BPS Change - H1, 2022 (O) - H1, 2021
(-) 82 ↓
The comparative analysis and market growth rate of global venous thromboembolism treatment market as studied by Future Market Insights, will show a negative BPS growth in H1-2022 outlook as compared to H1-2022 projected period by 50 BPS. A decline in the BPS growth is expected in H1-2022 as well, over H1- 2021 duration with 82 Basis Point Share (BPS).
According to FMI analysis, the decline in BPS values is attributed to the treatment inefficiency for acute coronary event, and the resultant decrease in the positive treatment outcomes associated with venous thromboembolism treatment.
Moreover, for patients with increased length of hospital stay, the treatment option is ineffective, and results in poor patient compliance. This is a major cause for the resultant decline in the BPS.
Additionally, the market is subject to macroeconomic and industry dynamics which include regulatory requirements for drugs and therapeutics, device licensing and distribution, and treatment compliance.
The key developments in the market include the induction of direct oral anticoagulants, which may promote the growth and propulsion of the market during the forecasted years.
2014-2021 Venous Thromboembolism Treatment Market Outlook in Comparison to 2022-2029 Growth Forecast
Sales in the global venous thromboembolism treatment market totaled US$ 1.46 Bn in 2021, as per FMI. The market is estimated to expand by 1.5x over the forecast period 2022-2029
Venous thromboembolism is a condition in which blood clots are formed in deep veins of arms, groin, or legs and travels with the blood circulation, lodging in the lungs. It can restrict the flow of blood and oxygen damaging the body’s tissues and organs. Hence, growing awareness regarding the severity of the diseases across developing economies is favoring the growth in the market.
Rising prevalence of pulmonary embolism disease is one of the leading factors favoring the growth in the market. For instance, according to the Centers for Disease Control and Prevention, around 900,000 people in the U.S. are affected by pulmonary embolism, causing around 60,000 to 100,000 deaths every year.
As several patients are at high risk of developing more serious venous thromboembolism, therapeutics such as retrievable vena cava filters are increasingly being used to stop the progression of malignant pulmonary embolism. This is expected to augment the sales of venous thromboembolism treatments in the market.
Will the Rising Surgical Procedures Drive Venous Thromboembolism Treatment Market?
A substantial rise in surgical procedures conducted worldwide is registered over the last few years. This can be attributable to the rising burden of various chronic ailments around the world. Moreover, higher demand for cosmetics surgeries also will create opportunities for growth of the market.
According to a report by the American Society of Plastic Surgeons, around 15.6 million cosmetic procedures and 6.8 million reconstructive procedures were reported to be conducted across the U.S. in 2020. As surgical procedures increase the risk of blood clots in the body causing pulmonary embolism, this rise in surgeries is expected to create high demand for the prevention and therapeutics of the disease, creating growth opportunities in the market.
In addition, increasing number of research and development (R&D) activities for the development of novel devices, filters, and therapeutics across countries such as the U.S., China, the U.K., and India are favoring the growth in the market. On account of this, the global venous thromboembolism treatment market is poised to total US$ 1.91 Bn through 2029, expanding at 3.7% CAGR during the forecast period.
Find your sweet spots for generating winning opportunities in this market.
Country-wise Analysis
What are the Factors Facilitating the Growth in the U.S. Venous Thromboembolism Treatment Market?
“Favorable Reimbursement Policies Favoring Demand for Thromboembolic Therapy in the U.S.”
As per Future Market Insights (FMI), the U.S. is estimated to emerge as one of the largest revenue-generating markets for venous thromboembolism treatment.
Presence of favorable reimbursement policies facilitating treatment of various diseases, covering procedures such as chemotherapy and thromboembolic therapy in the U.S. is favoring the growth in the market. In addition, the country also offers high incentives to doctors and physicians to use filters for prophylactic treatments. These factors are estimated to accelerate the sales of venous thromboembolism treatments in the U.S.
Why is the Sales of Venous Thromboembolism Treatment Increasing in the U.K.?
“Growing Retrieval Rate of Vena Cava Filters to Push Demand for Venous Thromboembolism Management”
FMI states that the U.K. is anticipated to account for a significant share in the Europe venous thromboembolism treatment market over the assessment period.
Vena cava filters can cause serious medical complications post-surgical implantation. Hence, these filters have to be removed once the risk of pulmonary embolism declines.
With rising instance of vena cava filters being left inside patients, the demand for venous thromboembolism management rapidly increasing. Thus, market players in the country are aiming at developing advanced tracking systems for patients follow-up to ensure the removal of these filters. Such developments in the country are facilitating the growth in the market.
Why is the Demand for Venous Thromboembolism Treatment Burgeoning in China?
“Increasing Burden of Lifestyle Diseases Fueling the Venous Thromboembolism TreatmentDeviceSales”
The China venous thromboembolism treatment market is projected to register growth at a rapid CAGR between 2022 and 2029, as per FMI.
Growing prevalence of lifestyle disorders such as diabetes, obesity, low blood pressure, and others are significantly increasing the burden of pulmonary embolism as these disorders increase the risk of blood clots.
As venous thromboembolism treatment devices such as thrombectomy devices and blood clot retrieval devices assist in dissolving the blood clots at initials stages. Consequently the rising demand for these devices is favoring the growth in the country.
Category-wise Insights
Which Product Category Holds Dominance?
“Rising Inclination towards Minimally Invasive Treatment Augmenting the Demand Venous Thromboembolism Management Devices”
Future Market Insights forecasts catheter-directed thrombolysis devices to account for maximum venous thromboembolism treatment sales through 2029.
Catheter-directed thrombolysis devices are popular adjunct to percutaneous mechanical thrombectomy devices which uses x-ray imaging to guide medical device or medication to the site of blood clots and dissolve it.
Hence, growing patient inclination towards adopting minimally invasive procedures for the treatment of pulmonary embolism is propelling the demand for such venous thromboembolism management devices, driving the growth in the segment.
Why is the Deep Venous Thrombosis Leading the Market?
“Growing Risk of Blood Clots to Create Tailwind for Deep Venous Thrombosis Treatment”
As per FMI, the deep venous thrombosis segment is estimated to lead the global venous thromboembolism treatment market in terms of disease indication. It is expected to account for nearly 68.4% of the total sales in 2022.
Increasing risk of blood clots, causing deep venous thrombosis, due to growing cases of cancer, pregnancy, and cardiovascular diseases, especially across developing economies such as China, India, Australia, and others is propelling the demand in the deep venous thrombosis segment.
Why is the Sales of Venous Thromboembolism Treatment Rising in Hospitals?
“Presence of Favorable Reimbursement Policies to Augment the Sales ofThromboembolism Treatment”
In terms of end user, the global venous thromboembolism treatment market is segmented into hospital, catheterization laboratories, and ambulatory surgical centers. FMI states that the hospital segment is projected to register robust growth in the market during the forecast period.
Increasing patient preference for visiting hospitals for the treatment of pulmonary embolism and deep venous thrombosis, owing to the presence of advanced medical infrastructure and favorable reimbursement policies is favoring the growth in the segment.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Competitive Landscape
Key players in the global venous thromboembolism treatment market are investing in research and development activities for launching novel devices and therapeutics. Some of the other companies are aiming at receiving product approvals for their new products to gain competitive edge. For instance,
In June 2021, Janssen Pharmaceuticals, Inc, a Belgium-based pharmaceutical company, announced receiving Food and Drug Administration (FDA) approval for its new products XARELTO® (rivaroxaban) for the treatment of two indications - deep venous thrombosis and pulmonary embolism. This will assist the company to strengthen its footprint in the market.
Scope of the Report
Attribute
Details
Forecast Period
2022 to 2029
Historical Data Available for
2014 to 2021
Market Analysis
US$ Billion for Value
Key Regions Covered
North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East & Africa
Key Countries Covered
USA, Canada, Germany, UK, France, Italy, Spain, Poland, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Vietnam, Indonesia, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, South Africa
Venous Thromboembolism Treatment Market by Category
By Product:
Non-Segmented Pneumatic Compression Pumps
Segmented Pneumatic Compression Pumps without Gradient
Segmented Pneumatic Compression Pumps with Calibrated Gradient
Upper Pneumatic Compression Sleeves
Lower Pneumatic Compression Sleeves
Permanent Inferior Vena Cava Filters
Retrievable Inferior Vena Cava Filters
Embolectomy Balloon Catheters
Percutaneous Thrombectomy Devices
Catheter-Directed Thrombolysis (CDT) Devices
By Disease Indication:
Deep Venous Thrombosis
Pulmonary Embolism
By End User:
Hospitals
Catheterisation Laboratories
Ambulatory Surgical Centers
By Region:
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa
Frequently Asked Questions
The venous thromboembolism treatment market is expected to surpass a valuation of US$ 1.46 Bn in 2021
The global venous thromboembolism treatment market grew at a 3.7% CAGR over the past assessment period 2014-2021.
The venous thromboembolism treatment market is expected to register steady growth, expanding a 3.7% CAGR between 2022 and 2029.
North America is estimated to lead the global venous thromboembolism treatment market, expanding at rapid CAGR through 2029.
Europe venous thromboembolism treatment market will hold a significant share over the assessment period 2022-2029.
In terms of indication, the deep venous thrombosis segment is expected to account for around 68.4% of the total venous thromboembolism treatment sales market in 2022.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation & Development Trends
4. Key Success Factors
4.1. Regulatory Scenario
4.2. Reimbursement Landscape
5. Global Venous Thromboembolism Treatment Market - Pricing Analysis
5.1. Regional Pricing Analysis By Product Type
5.2. Pricing Break-up
5.2.1. Manufacturer Level Pricing
5.2.2. Distributor Level Pricing
5.3. Global Average Pricing Analysis Benchmark
6. Global Venous Thromboembolism Treatment Market Demand (Value US$ Mn) Analysis 2014-2021 and Forecast, 2022-2029
6.1. Historical Market Value (US$ Mn) Analysis, 2014-2021
6.2. Current and Future Market Value (US$ Mn) Projections, 2022-2029
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
7. Market Background
7.1. Macro-Economic Factors
7.1.1. Global GDP Growth Outlook
7.1.2. Global Healthcare Expenditure Outlook
7.2. Forecast Factors - Relevance & Impact
7.2.1. High prevalence of Venous Thromboembolism
7.2.2. Increasing demand for device treatment over drugs
7.2.3. Technological advancements in Venous Thromboembolism
7.2.4. Reimbursement
7.3. Value Chain
7.4. Market Dynamics
7.4.1. Drivers
7.4.2. Restraints
7.4.3. Opportunity Analysis
8. Global Venous Thromboembolism Treatment Market Analysis 2014-2021 and Forecast 2022-2029, by Product Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) & Volume Analysis By Product Type, 2014 - 2021
8.3. Current and Future Market Size (US$ Mn) & Volume Analysis and Forecast By Product Type, 2021 - 2021
8.3.1. Non-Segmented Pneumatic Compression Pumps
8.3.2. Segmented Pneumatic Compression Pumps without Gradient
8.3.3. Segmented Pneumatic Compression Pumps with Calibrated Gradient
8.3.4. Upper Pneumatic Compression Sleeves
8.3.5. Lower Pneumatic Compression Sleeves
8.3.6. Permanent Inferior Vena Cava Filters
8.3.7. Retrievable Inferior Vena Cava Filters
8.3.8. Embolectomy Balloon Catheters
8.3.9. Percutaneous Thrombectomy Devices
8.3.10. Catheter-Directed Thrombolysis (CDT) Devices
8.4. Market Attractiveness Analysis By Product Type
9. Global Venous Thromboembolism Treatment Market Analysis 2014-2021 and Forecast 2022-2029, by Disease Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Disease Type, 2014 - 2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease Type, 2021 - 2021
9.3.1. Deep Venous Thrombosis
9.3.2. Pulmonary Embolism
9.4. Market Attractiveness Analysis By Disease Type
10. Global Venous Thromboembolism Treatment Market Analysis 2014-2021 and Forecast 2022-2029, by End User
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By End User, 2014 - 2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2021 - 2021
10.3.1. Hospitals
10.3.2. Ambulatory Surgical Centers
10.3.3. Independent Catheterization Laboratories
10.4. Market Attractiveness Analysis By End User
11. Global Venous Thromboembolism Treatment Market Analysis 2014-2021 and Forecast 2022-2029, by Region
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Region, 2014 - 2021
11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2021 - 2021
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. South Asia
11.3.5. East Asia
11.3.6. Oceania
11.3.7. Middle East & Africa (MEA)
11.4. Market Attractiveness Analysis By Region
12. North America Venous Thromboembolism Treatment Market Analysis 2014-2021 and Forecast 2022-2029
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Mn) & Volume Trend Analysis By Market Taxonomy, 2014 - 2021
12.4. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2022 - 2029
12.4.1. By Country
12.4.1.1. U.S.
12.4.1.2. Canada
12.4.2. By Product Type
12.4.3. By Disease Type
12.4.4. By End User
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Product Type
12.5.3. By Disease Type
12.5.4. By End User
12.6. Market Trends
12.7. Key Market Participants - Intensity Mapping
12.8. Drivers and Restraints - Impact Analysis
13. Latin America Venous Thromboembolism Treatment Market Analysis 2014-2021 and Forecast 2022-2029
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ Mn) & Volume Trend Analysis By Market Taxonomy, 2014 - 2021
13.4. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2022 - 2029
13.4.1. By Country
13.4.1.1. Brazil
13.4.1.2. Mexico
13.4.1.3. Rest of Latin America
13.4.2. By Product Type
13.4.3. By Disease Type
13.4.4. By End User
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Product Type
13.5.3. By Disease Type
13.5.4. By End User
13.6. Market Trends
13.7. Key Market Participants - Intensity Mapping
13.8. Drivers and Restraints - Impact Analysis
14. Europe Venous Thromboembolism Treatment Market Analysis 2014-2021 and Forecast 2022-2029
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Mn) & Volume Trend Analysis By Market Taxonomy, 2014 - 2021
14.4. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2022 - 2029
14.4.1. By Country
14.4.1.1. Germany
14.4.1.2. Italy
14.4.1.3. France
14.4.1.4. U.K.
14.4.1.5. Spain
14.4.1.6. Russia
14.4.1.7. BENELUX
14.4.1.8. Rest of Europe
14.4.2. By Product Type
14.4.3. By Disease Type
14.4.4. By End User
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Product Type
14.5.3. By Disease Type
14.5.4. By End User
14.6. Market Trends
14.7. Key Market Participants - Intensity Mapping
14.8. Drivers and Restraints - Impact Analysis
15. South Asia Venous Thromboembolism Treatment Market Analysis 2014-2021 and Forecast 2022-2029
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn) & Volume Trend Analysis By Market Taxonomy, 2014 - 2021
15.4. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2022 - 2029
15.4.1. By Country
15.4.1.1. India
15.4.1.2. Thailand
15.4.1.3. Indonesia
15.4.1.4. Malaysia
15.4.1.5. Rest of South Asia
15.4.2. By Product Type
15.4.3. By Disease Type
15.4.4. By End User
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Product Type
15.5.3. By Disease Type
15.5.4. By End User
15.6. Market Trends
15.7. Key Market Participants - Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis
16. East Asia Venous Thromboembolism Treatment Market Analysis 2014-2021 and Forecast 2022-2029
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) & Volume Trend Analysis By Market Taxonomy, 2014 - 2021
16.4. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2022 - 2029
16.4.1. By Country
16.4.1.1. China
16.4.1.2. Japan
16.4.1.3. South Korea
16.4.2. By Product Type
16.4.3. By Disease Type
16.4.4. By End User
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Product Type
16.5.3. By Disease Type
16.5.4. By End User
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis
17. Oceania Venous Thromboembolism Treatment Market Analysis 2014-2021 and Forecast 2022-2029
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Size (US$ Mn) & Volume Trend Analysis By Market Taxonomy, 2014 - 2021
17.4. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2022 - 2029
17.4.1. By Country
17.4.1.1. Australia
17.4.1.2. New Zealand
17.4.2. By Product Type
17.4.3. By Disease Type
17.4.4. By End User
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Product Type
17.5.3. By Disease Type
17.5.4. By End User
17.6. Market Trends
17.7. Key Market Participants - Intensity Mapping
17.8. Drivers and Restraints - Impact Analysis
18. Middle East and Africa Venous Thromboembolism Treatment Market Analysis 2014-2021 and Forecast 2022-2029
18.1. Introduction
18.2. Pricing Analysis
18.3. Historical Market Size (US$ Mn) & Volume Trend Analysis By Market Taxonomy, 2014 - 2021
18.4. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2022 - 2029
18.4.1. By Country
18.4.1.1. GCC Countries
18.4.1.2. South Africa
18.4.1.3. Turkey
18.4.1.4. Northern Africa
18.4.1.5. Rest of Middle East and Africa
18.4.2. By Product Type
18.4.3. By Disease Type
18.4.4. By End User
18.5.Market Attractiveness Analysis
18.5.1. By Country
18.5.2. By Product Type
18.5.3. By Disease Type
18.5.4. By End User
18.6. Market Trends
18.7. Key Market Participants - Intensity Mapping
18.8. Drivers and Restraints - Impact Analysis
19. Emerging Countries Venous Thromboembolism Treatment Market Analysis 2014-2021 and Forecast 2022-2029
19.1. Introduction
19.1.1. Market Value Proportion Analysis, By Key Countries
19.1.2. Global Vs. Country Growth Comparison
19.2. China Venous Thromboembolism Treatment Market Analysis
19.2.1. Introduction
19.2.2. Pricing Analysis
19.2.3. PEST Analysis
19.2.4. Market Value Proportion Analysis by Market Taxonomy
19.2.5. Market Value (US$ Mn) & Volume Analysis and Forecast by Market Taxonomy
19.2.5.1. By Product Type
19.2.5.2. By Disease Type
19.2.5.3. By End User
19.2.6. China Venous Thromboembolism Treatment Market - Competition Landscape
19.3. India Venous Thromboembolism Treatment Market Analysis
19.3.1. Introduction
19.3.2. Pricing Analysis
19.3.3. PEST Analysis
19.3.4. Market Value Proportion & Volume Analysis by Market Taxonomy
19.3.5. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
19.3.5.1. By Product Type
19.3.5.2. By Disease Type
19.3.5.3. By End User
19.3.6. India Venous Thromboembolism Treatment Market - Competition Landscape
19.4. South Korea Venous Thromboembolism Treatment Market Analysis
19.4.1. Introduction
19.4.2. Pricing Analysis
19.4.3. PEST Analysis
19.4.4. Market Value Proportion & Volume Analysis by Market Taxonomy
19.4.5. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
19.4.5.1. By Product Type
19.4.5.2. By Disease Type
19.4.5.3. By End User
19.4.6. South Korea Venous Thromboembolism Treatment Market - Competition Landscape
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies (Venous Thromboembolism Treatment)
20.2. Market Concentration
20.3. Market Share Analysis of Top Players
20.4. Market Presence Analysis
20.4.1. By Regional footprint of Players
20.4.2. Product foot print by Players
20.4.3. Channel Foot Print by Players
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Deep Dive
21.2.1. ArjoHuntleigh AB
21.2.1.1. Overview
21.2.1.2. Product Portfolio
21.2.1.3. Profitability by Market Segments (Product/Channel/Region)
21.2.1.4. Sales Footprint
21.2.1.5. Strategy Overview
21.2.1.5.1. Marketing Strategy
21.2.1.5.2. Product Strategy
21.2.1.5.3. Channel Strategy
21.2.2. DaeSung Maref Co., Ltd.
21.2.3. DJO Global
21.2.4. Argon Medical Devices
21.2.5. Lifetech Scientific
21.2.6. Cardinal Health
21.2.7. ALN Implants Chirurgicaux
21.2.8. Boston Scientific Corporation
21.2.9. Cook Medical
21.2.10. Volcano Corporation
21.2.11. Medtronic plc
21.2.12. Stryker Corporation
21.2.13. AngioDynamics Inc.
22. Assumptions and Acronyms Used23. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 01 : Global Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type
Table 02 : Global Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type
Table 03 : Global Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Disease Indication
Table 04 : Global Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
Table 05 : Global Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Region
Table 06 : North America Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country
Table 07 : North America Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type
Table 08 : North America Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type
Table 09 : North America Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Disease Indication
Table 10 : North America Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
Table 11 : Latin America Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country
Table 12 : Latin America Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type
Table 13 : Latin America Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type
Table 14 : Latin America Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Disease Indication
Table 15 : Latin America Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
Table 16 : Europe Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country
Table 17 : Europe Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type
Table 18 : Europe Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type
Table 19 : Europe Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Disease Indication
Table 20 : Europe Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
Table 21 : South Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country
Table 22 : South Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type
Table 23 : South Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type
Table 24 : South Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Disease Indication
Table 25 : South Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
Table 26 : East Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country
Table 27 : East Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type
Table 28 : East Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type
Table 29 : East Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Disease Indication
Table 30 : East Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
Table 31 : Oceania Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country
Table 32 : Oceania Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type
Table 33 : Oceania Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type
Table 34 : Oceania Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Disease Indication
Table 35 : Oceania Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
Table 36 : MEA Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country
Table 37 : MEA Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type
Table 38 : MEA Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type
Table 39 : MEA Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Disease Indication
Table 40 : MEA Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
Table 41 : Emerging Venous Thromboembolism Treatment Market Value Proportion Analysis 2014-2021 and Forecast 2022-2029, By Country
Table 42 : Emerging and Global Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029
Table 43 : China Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type
Table 44 : China Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type
Table 45 : China Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Disease Indication
Table 46 : China Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
Table 47 : South Korea Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type
Table 48 : South Korea Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type
Table 49 : South Korea Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Disease Indication
Table 50 : South Korea Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
Table 51 : India Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type
Table 52 : India Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type
Table 53 : India Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Disease Indication
Table 54 : India Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
